Herpes zoster recurrences more frequent than previously reported
- PMID: 21220354
- PMCID: PMC3031432
- DOI: 10.4065/mcp.2010.0618
Herpes zoster recurrences more frequent than previously reported
Abstract
Objective: To present population-based estimates of herpes zoster (HZ) recurrence rates among adults.
Patients and methods: To identify recurrent cases of HZ, we reviewed the medical records (through December 31, 2007) of all Olmsted County, Minnesota, residents aged 22 years or older who had an incident case of HZ between January 1, 1996, and December 31, 2001. Kaplan-Meier curves and Cox regression models were used to describe recurrences by age, immune status, and presence of prolonged pain at the time of the incident HZ episode.
Results: Of the 1669 persons with a medically documented episode of HZ, 95 had 105 recurrences (8 persons with >1 recurrence) by December 31, 2007, an average follow-up of 7.3 years. The Kaplan-Meier estimate of the recurrence rate at 8 years was 6.2%. With a maximum follow-up of 12 years, the time between HZ episodes in the same person varied from 96 days to 10 years. Recurrences were significantly more likely in persons with zoster-associated pain of 30 days or longer at the initial episode (hazard ratio, 2.80; 95% confidence interval, 1.84-4.27; P<.001) and in immunocompromised individuals (hazard ratio, 2.35; 95% confidence interval, 1.35-4.08; P=.006). Women and anyone aged 50 years or older at the index episode also had a greater likelihood of recurrence.
Conclusion: Rates of HZ recurrence appear to be comparable to rates of first HZ occurrence in immunocompetent individuals, suggesting that recurrence is sufficiently common to warrant investigation of vaccine prevention in this group.
Figures
Comment in
-
Frequency of herpes zoster recurrence.Mayo Clin Proc. 2011 Jun;86(6):586; author reply 586-7. doi: 10.4065/mcp.2011.0096. Mayo Clin Proc. 2011. PMID: 21628622 Free PMC article. No abstract available.
Similar articles
-
A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.Mayo Clin Proc. 2007 Nov;82(11):1341-9. doi: 10.4065/82.11.1341. Mayo Clin Proc. 2007. PMID: 17976353
-
Recurrence Rate of Herpes Zoster and Its Risk Factors: a Population-based Cohort Study.J Korean Med Sci. 2018 Dec 20;34(2):e1. doi: 10.3346/jkms.2019.34.e1. eCollection 2019 Jan 14. J Korean Med Sci. 2018. PMID: 30636941 Free PMC article.
-
Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.Hum Vaccin Immunother. 2015;11(5):1157-64. doi: 10.1080/21645515.2015.1016681. Hum Vaccin Immunother. 2015. PMID: 25806911 Free PMC article.
-
[Herpes Zoster and its prevention in Italy. Scientific consensus statement].Ig Sanita Pubbl. 2014 Jan-Feb;70(1):111-27. Ig Sanita Pubbl. 2014. PMID: 24770367 Italian.
-
Herpes zoster subunit vaccine for the prevention of herpes zoster.Am J Health Syst Pharm. 2018 Jun 15;75(12):861-869. doi: 10.2146/ajhp170399. Am J Health Syst Pharm. 2018. PMID: 29880523 Review.
Cited by
-
Associations of head and neck cancers with herpes zoster in the preceding five years.Sci Rep. 2024 Sep 15;14(1):21541. doi: 10.1038/s41598-024-72893-z. Sci Rep. 2024. PMID: 39278971 Free PMC article.
-
Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine.Biomolecules. 2024 Jun 22;14(7):739. doi: 10.3390/biom14070739. Biomolecules. 2024. PMID: 39062454 Free PMC article. Review.
-
[Clinical presentation and treatment of herpes zoster and postherpetic neuralgia].Dermatologie (Heidelb). 2024 Sep;75(9):733-742. doi: 10.1007/s00105-024-05367-y. Epub 2024 Jun 27. Dermatologie (Heidelb). 2024. PMID: 38935292 Review. German.
-
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain.Hum Vaccin Immunother. 2024 Dec 31;20(1):2366353. doi: 10.1080/21645515.2024.2366353. Epub 2024 Jun 26. Hum Vaccin Immunother. 2024. PMID: 38925145 Free PMC article.
-
Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling study.Hum Vaccin Immunother. 2024 Dec 31;20(1):2348839. doi: 10.1080/21645515.2024.2348839. Epub 2024 May 28. Hum Vaccin Immunother. 2024. PMID: 38804600 Free PMC article.
References
-
- Chien AJ, Olerud JE. Why do so many clinicians believe that recurrent zoster is common? Dermatol Online J. 2007;13(2):2 - PubMed
-
- Heskel NS, Hanifin JM. “Recurrent herpes zoster”: an unproved entity? J Am Acad Dermatol. 1984;10(3):486-490 - PubMed
-
- Horiuchi Y. Recurrent herpes zoster. J Dermatol. 1998;25(5):347-348 - PubMed
-
- Burkhart CN. Recurrent herpes zoster revisited [letter]. Int J Dermatol. 2002;41(8):528 - PubMed
-
- Bansal R. Recurrent herpes zoster. Int J Dermatol. 2001;40(8):542-543 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
